341 related articles for article (PubMed ID: 34777589)
1. Long non-coding RNA TMPO-AS1 promotes cell proliferation, migration, invasion and epithelial-to-mesenchymal transition in gallbladder carcinoma by regulating the microRNA-1179/E2F2 axis.
Sui Z; Sui X
Oncol Lett; 2021 Dec; 22(6):855. PubMed ID: 34777589
[TBL] [Abstract][Full Text] [Related]
2. LncRNA TMPO-AS1 promotes hepatocellular carcinoma cell proliferation, migration and invasion through sponging miR-329-3p to stimulate FOXK1-mediated AKT/mTOR signaling pathway.
Guo X; Wang Y
Cancer Med; 2020 Jul; 9(14):5235-5246. PubMed ID: 32462698
[TBL] [Abstract][Full Text] [Related]
3. Long noncoding TMPO antisense RNA 1 promotes hepatocellular carcinoma proliferation and epithelial-mesenchymal transition by targeting the microRNA-126-3p/LRP6/β-catenin axis.
Huang W; Chen Q; Dai J; Zhang Y; Yi Y; Wei X
Ann Transl Med; 2021 Nov; 9(22):1679. PubMed ID: 34988188
[TBL] [Abstract][Full Text] [Related]
4. Propofol suppresses hypoxia-induced esophageal cancer cell migration, invasion, and EMT through regulating lncRNA TMPO-AS1/miR-498 axis.
Gao M; Guo R; Lu X; Xu G; Luo S
Thorac Cancer; 2020 Sep; 11(9):2398-2405. PubMed ID: 32643321
[TBL] [Abstract][Full Text] [Related]
5. Long Non-Coding RNA TMPO-AS1 Promotes Cervical Cancer Cell Proliferation, Migration, and Invasion by Regulating miR-143-3p/ZEB1 Axis.
Gang X; Yuan M; Zhang J
Cancer Manag Res; 2020; 12():1587-1599. PubMed ID: 32184662
[TBL] [Abstract][Full Text] [Related]
6. Long non-coding RNA TMPO-AS1 serves as a tumor promoter in pancreatic carcinoma by regulating miR-383-5p/SOX11.
Xue F; Song X; Zhang S; Niu M; Cui Y; Wang Y; Zhao T
Oncol Lett; 2021 Apr; 21(4):255. PubMed ID: 33664819
[TBL] [Abstract][Full Text] [Related]
7. LncRNA TMPO-AS1 Aggravates the Development of Hepatocellular Carcinoma via miR-429/GOT1 Axis.
Liu X; Shen Z
Am J Med Sci; 2020 Dec; 360(6):711-720. PubMed ID: 32988599
[TBL] [Abstract][Full Text] [Related]
8. LncRNA TMPO-AS1 Promotes Proliferation and Invasion by Sponging miR-383-5p in Glioma Cells.
Liu G; Yang H; Cao L; Han K; Li G
Cancer Manag Res; 2020; 12():12001-12009. PubMed ID: 33262650
[TBL] [Abstract][Full Text] [Related]
9. Long Non-Coding RNA OIP5-AS1 Contributes to Gallbladder Cancer Cell Invasion and Migration by miR-143-3p Suppression.
Li J; Zhang H; Luo H
Cancer Manag Res; 2020; 12():12983-12992. PubMed ID: 33364844
[TBL] [Abstract][Full Text] [Related]
10. Long Non-Coding RNA TMPO-AS1 Promotes Cell Migration and Invasion by Sponging miR-140-5p and Inducing SOX4-Mediated EMT in Gastric Cancer.
Sun Y; Han C
Cancer Manag Res; 2020; 12():1261-1268. PubMed ID: 32110100
[TBL] [Abstract][Full Text] [Related]
11. Long non-coding RNA TUG1 promotes cell proliferation and metastasis by negatively regulating miR-300 in gallbladder carcinoma.
Ma F; Wang SH; Cai Q; Jin LY; Zhou D; Ding J; Quan ZW
Biomed Pharmacother; 2017 Apr; 88():863-869. PubMed ID: 28178615
[TBL] [Abstract][Full Text] [Related]
12. LncRNA TMPO-AS1 up-regulates the expression of HIF-1α and promotes the malignant phenotypes of retinoblastoma cells via sponging miR-199a-5p.
Peng X; Yan J; Cheng F
Pathol Res Pract; 2020 Apr; 216(4):152853. PubMed ID: 32139259
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of LncRNA AFAP1-AS1 predicts poor prognosis and promotes cells proliferation and invasion in gallbladder cancer.
Ma F; Wang SH; Cai Q; Zhang MD; Yang Y; Ding J
Biomed Pharmacother; 2016 Dec; 84():1249-1255. PubMed ID: 27810781
[TBL] [Abstract][Full Text] [Related]
14. lncRNA TMPO-AS1 Exerts Oncogenic Roles in HCC Through Regulating miR-320a/SERBP1 Axis.
Wang Z; Huang D; Huang J; Nie K; Li X; Yang X
Onco Targets Ther; 2020; 13():6539-6551. PubMed ID: 32753892
[TBL] [Abstract][Full Text] [Related]
15. CDKN2B-AS1 promotes the proliferation, clone formation, and invasion of nasopharyngeal carcinoma cells by regulating miR-98-5p/E2F2 axis.
Li Z; Cai X; Zou W; Zhang J
Am J Transl Res; 2021; 13(12):13406-13422. PubMed ID: 35035684
[TBL] [Abstract][Full Text] [Related]
16. LncRNA NNT-AS1 regulates the progression of lung cancer through the NNT-AS1/miR-3666/E2F2 axis.
Huang JW; Luo XY; Li ZH; Lang BP
Eur Rev Med Pharmacol Sci; 2020 Jan; 24(1):238-248. PubMed ID: 31957837
[TBL] [Abstract][Full Text] [Related]
17. LncRNA-TMPO-AS1 promotes apoptosis of osteosarcoma cells by targeting miR-329 and regulating E2F1.
Liu X; Wang H; Tao GL; Chu TB; Wang YX; Liu L
Eur Rev Med Pharmacol Sci; 2020 Nov; 24(21):11006-11015. PubMed ID: 33215415
[TBL] [Abstract][Full Text] [Related]
18. TMPO-AS1 promotes cervical cancer progression by upregulating RAB14 via sponging miR-577.
Yang J; Liang B; Hou S
J Gene Med; 2019 Nov; 21(11):e3125. PubMed ID: 31483914
[TBL] [Abstract][Full Text] [Related]
19. Down-Regulation of TMPO-AS1 Induces Apoptosis in Lung Carcinoma Cells by Regulating miR-143-3p/CDK1 Axis.
Li Q; Bian Y; Li Q
Technol Cancer Res Treat; 2021; 20():1533033820948880. PubMed ID: 33685293
[TBL] [Abstract][Full Text] [Related]
20. Long non-coding RNA TMPO-AS1 facilitates the progression of colorectal cancer cells via sponging miR-98-5p to upregulate BCAT1 expression.
Ye J; Yan Y; Xin L; Liu J; Tang T; Bao X
J Gastroenterol Hepatol; 2022 Jan; 37(1):144-153. PubMed ID: 34370878
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
